Why Veru Is Rising In Pre-market?

Veru Inc. (VERU) reported positive efficacy and safety results from a planned interim analysis of the placebo-controlled phase 3 COVID-19 trial evaluating oral sabizabulin 9 mg versus placebo in 150 hospitalized COVID-19 patients at high risk for Acute Respiratory Distress Syndrome. The Independent Data Safety Monitoring Committee recommended that the study be halted early due to efficacy. The company plans to meet with FDA to discuss next steps including the submission of an emergency use authorization application.

The phase 3 trial involved approximately 210 hospitalized moderate to severe COVID-19 patients who were at high. The company said Sabizabulin treatment resulted in a clinically and statistically meaningful 55% relative reduction in deaths in the intent to treat population. Sabizabulin treatment was well tolerated in this patient population, the company noted.

Shares of Veru Inc. were up 33% in pre-market trade on Monday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Communications Commission or FCC has granted SpaceX Services, Inc. authorization to use its Starlink satellite internet system on vehicles in motion. SpaceX, owned by Elon Musk, is allowed to operate consumer and enterprise Ku-band Earth Stations in Motion or ESIM using frequencies allocated to the fixed satellite service. The approval would help the company to expand its services to Loud Muscle Science, LLC is recalling certain Launch Sequence products in the United States and Canada citing the presence of undeclared Tadalafil, the U.S. Food and Drug Administration said. These tainted Launch Sequence Capsule products are marketed as dietary supplements for male sexual enhancement. The U.S. Food and Drug Administration announced the intended availability of around 17 million bottles equivalent of general infant formula to be imported from New Zealand and Ireland. Under the FDA's enforcement discretion to source more infant formula to the U.S., French food company Danone SA will send 555,000 cans Aptamil Gold Plus from New Zealand.
Follow RTT